Long-term treatment with Danazol increases expression of C1-INH mRNA in PBMC of patients with hereditary angioedema

被引：0
|
作者：
Cicardi, M [1 ]
Pappalardo, E [1 ]
Zingale, LC [1 ]
Gioffré, D [1 ]
Agostoni, A [1 ]
机构：
[1] Univ Milan, IRCCS, Maggiore Hosp, Dept Internal Med, Milan, Italy
来源：
MOLECULAR IMMUNOLOGY | 1999年 / 36卷 / 4-5期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
134
引用
收藏
页码：313 / 313
页数：1
相关论文
共 50 条
  • [41] C1-Esterase inhibitor (C1-INH) functional activity of subcutaneous C1-INH for the prevention of Hereditary Angioedema (HAE) attacks: Pharmacokinetic comparison in adolescent and adult patients
    Christiansen, S.
    Zuraw, B.
    Feuersenger, H.
    Pragst, I
    Pawaskar, D.
    ALLERGY, 2018, 73 : 613 - 614
  • [42] Individualized treatment with subcutaneous pnfC1-INH as long-term prophylaxis in patients with hereditary angioedema due to C1 inhibitor deficiency
    Lleonart Bellfill, R.
    Sala-Cunill, A.
    Andres-Lopez, B.
    Guilarte, M.
    ALLERGY, 2021, 76 : 232 - 232
  • [43] Does long-term treatment alter the pharmacokinetics of human C1-esterase-inhibitor (C1-INH) in HAE patients?
    Martinez-Saguer, Inmaculada
    Rusicke, Eva
    Aygoren-Pursun, Emel
    Klingebiel, Thomas
    Kreuz, Wolfhart
    MOLECULAR IMMUNOLOGY, 2008, 45 (16) : 4156 - 4157
  • [44] Efficacy and safety of long-term prophylaxis with C1 inhibitor (C1INH) concentrate in patients with hereditary Angioedema (HAE)
    Uraw, B.
    Busse, P.
    White, M.
    Jacobs, J.
    Lumry, W.
    Baker, J.
    Hurewitz, D.
    Manning, M.
    Koleilat, M.
    Friedman, R. A.
    Wilkinson, R.
    Cartwright, W. E.
    Tanner, D.
    Kohler, G.
    Gunther, G.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S272 - S272
  • [45] Clinical trial of C1-INH for treatment of ACEi-induced angioedema
    Wilkerson, Gentry
    Dakessian, Alik
    Moellman, Joseph J.
    Bernstein, Jonathan A.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2023, 68 : 196 - 197
  • [46] C1-INH Therapy Improves Health-Related Quality of Life Measures in Patients with Hereditary Angioedema
    Bewtra, A.
    Jacobson, K. W.
    Craig, T.
    Packer, F.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S103 - S103
  • [47] Hereditary angioedema with C1 inhibitor (C1-INH) deficit: the strength of recognition (51 cases)
    Fragnan, N. T. M. L.
    Tolentino, A. L. N.
    Borba, G. B.
    Oliveira, A. C.
    Simoes, J. A.
    Palma, S. M. U.
    Constantino-Silva, R. N.
    Grumach, A. S.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2018, 51 (12)
  • [48] A sporadic case of hereditary angioedema with a heterozygous large deletion including C1-INH gene
    Iwamoto, Kazumasa
    Tanaka, Akio
    Kawai, Mikio
    Mihara, Shoji
    Hide, Michihiro
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S77 - S77
  • [49] Intravenous C1-INH [C1-INH(IV)] Use Among Patients with Hereditary Angioedema (HAE) in the United States (US) and Associated Health Care Resource Utilization (HCRU)
    Riedl, Marc A.
    Banerji, Aleena
    Manning, Michael E.
    Burrell, Earl
    Joshi, Namita
    Patel, Dipen
    Machnig, Thomas
    Tai, Ming-Hui
    Watson, Douglas
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB231 - AB231
  • [50] Evaluating adherence to long-term prophylaxis treatment with danazol in adult hereditary angioedema patients: A real life study
    Demir, Semra
    Unal, Derya
    Olgac, Muge
    Gelincik, Asli
    Coskun, Raif
    Colakoglu, Bahauddin
    Buyukozturk, Suna
    MARMARA MEDICAL JOURNAL, 2019, 32 (01): : 7 - 13
12345